SpotDoc, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
SpotDoc, Inc. - overview
Established
2023
Location
The Villages, FL, US
Primary Industry
Medical Devices & Equipment
About
SpotDoc, Inc. , located in the US, specializes in advanced dermatology solutions, emphasizing early skin cancer detection through its proprietary SpotCheck 360 technology, which utilizes AI to enhance patient diagnostics and care. SpotDoc, Inc. is dedicated to providing comprehensive dermatological services, focusing on early detection of skin cancer.
The company was founded in 2023 in The Villages, US. As of September 2025, SpotDoc, Inc. has completed one deal, securing venture funding from Oncology Ventures, aimed at enhancing their clinical imaging and analysis platform. SpotDoc specializes in advanced dermatology services, particularly in early skin cancer detection utilizing its proprietary SpotCheck 360 technology.
This AI-powered imaging system captures the entire skin surface in a single session, providing a thorough baseline for monitoring. SpotDoc addresses the rising incidence of melanoma and other skin cancers, aiming to offer efficient screenings that minimize unnecessary biopsies. Their services cater to individuals concerned about skin health, with clinics operating in New York, New Jersey, and Florida, while exploring further market expansions. Revenue for SpotDoc is generated through direct transactions with consumers seeking skin cancer screenings and advanced imaging services.
Patients can book appointments at their flagship clinic or partner locations, undergoing full-body scans with the SpotCheck 360 technology. The pricing model includes individual service fees for comprehensive skin cancer screenings. Additionally, SpotDoc collaborates with dermatology clinics that integrate its technology, supporting a B2B partnership framework. This focus on advanced technology and personalized care positions SpotDoc to meet the growing demand for skin cancer detection and management solutions.
In September 2025, SpotDoc, Inc. raised an undisclosed amount of venture funding from new investor Oncology Ventures. The company plans to utilize this funding to enhance the deployment of its imaging and analysis platform for clinical use. SpotDoc aims to launch new products and expand its services into new markets, with a specific focus on increasing its footprint in additional regions, thus improving access to its innovative skin cancer detection solutions.
Current Investors
Oncology Ventures
Primary Industry
Medical Devices & Equipment
Sub Industries
Clinics/Outpatient Services, Healthcare IT, Dermatology, Oncology/Cancer Treatment, Diagnostic Equipment
Website
www.spotdoc.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Early Stage
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.